| 09/09 | ASTELLAS PHARMA : Updates “Contact for Potential Acquisition of ' R&D Prog.. | PU |
| 09/02 | ASTELLAS PHARMA : Nitto, and M. Heart Partnering for ECG testing service | PU |
| 09/01 | Astellas Provides Update on ASPIRO Clinical Trial of AT132 in Patients with X.. | CI |
| 08/31 | ASTELLAS PHARMA : Announces Personnel Changes | PU |
| 08/30 | ASTELLAS PHARMA : Launches its Corporate Website's New Modalities～Approac.. | PU |
| 08/20 | SECTOR UPDATE : Health Care Stocks Mixed Premarket Friday | MT |
| 08/20 | FIBROGEN : Receives $120 Million Milestone Payment With Approval of Evrenzo in E.. | MT |
| 08/20 | ASTELLAS PHARMA : Receives European Commission Approval for First-in-Class EVREN.. | PU |
| 08/19 | ASTELLAS PHARMA : Receives European Commission Approval for First-in-Class EVREN.. | AQ |
| 08/19 | ASTELLAS PHARMA : Receives EC Approval for First-inClass EVRENZO (roxadustat) fo.. | PU |
| 08/19 | Astellas Receives EC Approval for First-Inclass Evrenzo for Adult Patients wi.. | CI |
| 08/18 | Nikkei snaps 4-day losing streak, but Delta worries persist | RE |
| 08/17 | Japanese shares bounce back as defensive stocks gain | RE |
| 08/17 | PRESS RELEASE : Basilea reports strong financial results for half-year 2021 with.. | DJ |
| 08/11 | FDA Rejects FibroGen's Roxadustat for Anemia of Chronic Kidney Disease | DJ |
| 08/06 | ASTELLAS PHARMA : Reforms Research Organization | PU |
| 08/05 | Modalis Announces Completion of a Research Collaboration on Angelman Syndrome.. | CI |
| 07/30 | ASTELLAS PHARMA : and Minovia Therapeutics Announce Strategic Collaboration for .. | BU |
| 07/30 | Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel .. | CI |
| 07/30 | Astellas Pharma Inc. Revises Earnings Guidance for the Full Year 2022 | CI |
| 07/30 | Astellas Pharma Inc. Reports Earnings Results for the First Quarter Ended Jun.. | CI |
| 07/29 | ASTELLAS PHARMA : Financial Results (Q1/FY2021) | PU |
| 07/29 | ASTELLAS PHARMA : Presentation Material for Information Meeting (Q1/FY2021) | PU |
| 07/29 | ASTELLAS PHARMA : Supplementary Documents (Q1/FY2021) | PU |
| 07/20 | The U.S. Food and Drug Administration Approves Astellas Pharma Inc.'s Supplem.. | CI |
| 07/15 | Piers Morgan Joins Pharnext's Board of Directors | DJ |
| 07/15 | Piers Morgan rejoint le Conseil d'Administration de Pharnext | DJ |
| 07/13 | ExCellThera and Astellas Enters into a License for the Use of Molecule UM171 .. | CI |
| 07/12 | Affinivax and Astellas Presents Safety and Immunogenicity Data from Phase 2 S.. | CI |
| 07/12 | ASTELLAS PHARMA : U.S. FDA Grants Regular Approval and Expands Indication for PA.. | AQ |
| 07/11 | ASTELLAS PHARMA : U.S. FDA Grants Regular Approval and Expands Indication for PA.. | PU |
| 07/09 | ASTELLAS PHARMA : U.S. FDA Grants Regular Approval and Expands Indication for PA.. | BU |
| 06/29 | ASTELLAS PHARMA : Corporate Governance Report | PU |
| 06/28 | ASTELLAS PHARMA : Receives Positive CHMP Opinion for EVRENZO (roxadustat) for Ad.. | PU |
| 06/25 | FIBROGEN : Gets Positive Opinion From European Panel for Roxadustat in Patients .. | MT |
| 06/25 | Astellas Receives Positive CHMP Opinion for Evrenzo™ for Adult Patients with .. | CI |
| 06/24 | PFIZER : First participant dosed in pfizer's pivotal phase 3 talapro-3 combinati.. | AQ |
| 06/21 | Astellas Pharma to Incur Nearly $196 Million Impairment Loss From Termination.. | MT |
| 06/17 | ASTELLAS PHARMA : Notice Regarding Impairment Loss Following the Termination of .. | PU |
| 06/16 | ASTELLAS PHARMA : Transfers Five Legacy Products in Europe, Russia, CIS and Asia.. | PU |
| 06/09 | ASTELLAS PHARMA : New Research Reflects Astellas' Commitment to Acute Myeloid Le.. | AQ |
| 06/08 | Heavyweights pull Nikkei lower, Topix gains on drugmakers' boost | RE |
| 06/07 | Nikkei falls as market heavyweights offset gains in drugmakers | RE |
| 06/02 | ASTELLAS PHARMA : Reviewing capabilities for sustainable growth - Astellas Will .. | PU |
| 06/02 | PRESS RELEASE : MorphoSys to Acquire Constellation -2- | DJ |
| 05/31 | Japanese shares end lower on profit-booking, drugmakers limit losses | RE |
| 05/30 | Japanese shares retreat from 3-week high; drugmakers limit losses | RE |
| 05/26 | Japanese shares fall on profit-taking, pandemic worries | RE |
| 05/20 | ASTELLAS PHARMA : and Seagen Announce Updated Results from Two Trials of PADCEV .. | AQ |
| 05/19 | ASTELLAS PHARMA : Seagen and Astellas Announce Updated Results from Two Trials o.. | BU |
| 05/18 | Astellas to Present Data from Expanding Oncology Portfolio During the 2021 AS.. | AQ |
| 05/14 | Japan's Ministry of Health, Labour and Welfare Grants Astellas Pharma Inc. Pr.. | CI |
| 05/12 | ASTELLAS PHARMA : Notice Regarding Continuation of the Performance-linked Stock .. | PU |
| 05/11 | PRESS RELEASE : AMSilk raises EUR 29M to accelerate commercialization of its hig.. | DJ |
| 05/11 | PRESS RELEASE : MIG portfolio company AMSilk completes EUR29 million financing r.. | DJ |
| 05/11 | Autobahn Therapeutics, Inc. acquired global rights to ASP3652 from Astellas P.. | CI |
| 05/06 | ASTELLAS PHARMA : ' XTANDI (enzalutamide) Approved by European Commission for Me.. | PU |
| 05/05 | ASTELLAS PHARMA : ' XTANDI (enzalutamide) Approved by European Commission for Me.. | AQ |
| 05/04 | Astellas' XTANDI™ (enzalutamide) Approved by European Commission for Men with.. | CI |
| 04/30 | Astellas Pharma Inc. Terminates License and Collaboration Agreement with Cyto.. | CI |
| 04/28 | ASTELLAS PHARMA INC. : - Notice Regarding Impairment Loss for Investigational Ge.. | AQ |
| 04/28 | ASTELLAS PHARMA INC. : - Change of Directors | AQ |
| 04/27 | PRESS RELEASE : MIG AG records 2020 as the most successful year in its company h.. | DJ |
| 04/27 | ASTELLAS PHARMA : Change of Directors | PU |
| 04/27 | Astellas Pharma Inc. Announces Keiko Yamagami to Resign as Director | CI |
| 04/26 | ASTELLAS PHARMA : Notice Regarding Impairment Loss for Investigational Gene Ther.. | PU |
| 04/26 | Astellas Pharma Inc. Reports Earnings Results for the Year Ended March 31, 20.. | CI |
| 04/22 | Zenith Epigenetics Announces Clinical Collaboration with Astellas | CI |
| 04/20 | ASTELLAS PHARMA : and Seagen Announce U.S. FDA Acceptance of Two Supplemental Bi.. | AQ |
| 04/20 | ASTELLAS PHARMA : and Seagen Announce FDA Acceptance of Two Supplemental Biologi.. | PU |
| 04/19 | SEAGEN : Astellas' Biologics License Applications for Bladder Cancer Drug Candid.. | MT |
| 04/14 | SHANGHAI STOCK EXCHANGE B SHARES IND : China Opens Innovative Medicines, Medical.. | MT |
| 04/13 | ASTELLAS PHARMA : Updates 'Contact for Potential Acquisition of ' R&D Programs' .. | AQ |
| 04/07 | PRESS RELEASE : T-knife Therapeutics Announces the Appointment of Donald Wuchter.. | DJ |
| 04/04 | ASTELLAS PHARMA : and TOA EIYO Announce Termination of Distribution Agreement | PU |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
